Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Achillion Pharmaceuticals Is Soaring 19.5% Today

TheMotleyFool

0 0

Here's Why Achillion Pharmaceuticals Is Soaring 19.5% Today

After Achillion Pharmaceuticals (NASDAQ: ACHN) priced its shares that Johnson & Johnson (NYSE: JNJ) is selling at $2.75 each, the company is rallying back 19.5% as of 3:15 p.m. EST.

Johnson & Johnson walked away from a licensing deal with Achillion Pharmaceuticals and its hepatitis C drug pipeline earlier this year, leading to speculation that J&J would unload the $225 million worth of Achillion Pharmaceuticals stock it acquired in 2015.

IMAGE SOURCE: GETTY IMAGES.

Source: Fool.com